Research library
Longevity/cofactor

NAD+

Canonical identity: Nicotinamide adenine dinucleotide

Also indexed as: NAD · Nicotinamide adenine dinucleotide

A central redox and metabolic cofactor; not a peptide despite its placement in the compound catalog.

Evidence level

Human research, limited or context-specific

Verified against the linked source set on 2026-08-20.

What it is

NAD+ is a coenzyme involved in electron transfer and enzyme systems including sirtuins and PARP-related biology.

Mechanism and research questions

  • NAD+/NADH balance participates in cellular energy metabolism.
  • NAD+-consuming enzymes make tissue availability and route important research variables.

Human evidence

Human studies exist for NAD-related interventions, but the results are not interchangeable across routes or products.

Preclinical / mechanistic evidence

Cell and animal work investigates aging biology, metabolism, DNA repair, and mitochondrial function.

Evidence summary

NAD+ biology is well established, while clinical claims about supplementation or infusion depend on specific formulations and trials.

Limits and interpretation

  • NAD+ is a cofactor, not a peptide drug class.
  • Route and stability can materially change the research question.
  • No wellness or anti-aging guarantee is made.

Regulatory and identity note

Research cofactor; product and route determine regulatory treatment.

Research summaries reflect primary literature, patent landscapes, and regulatory status reports at the time of review. They do not constitute therapeutic advice, endorsement, or claims regarding unauthorized preparations.